4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mouse models of Japanese encephalitis virus infection: A systematic review and meta-analysis using a meta-regression approach

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Japanese encephalitis (JE) virus (JEV) remains a leading cause of neurological infection across Asia. The high lethality of disease and absence of effective therapies mean that standardised animal models will be crucial in developing therapeutics. However, published mouse models are heterogeneous. We performed a systematic review, meta-analysis and meta-regression of published JEV mouse experiments to investigate the variation in model parameters, assess homogeneity and test the relationship of key variables against mortality.

          Methodology/ Principal findings

          A PubMed search was performed up to August 2020. 1991 publications were identified, of which 127 met inclusion criteria, with data for 5026 individual mice across 487 experimental groups. Quality assessment was performed using a modified CAMARADES criteria and demonstrated incomplete reporting with a median quality score of 10/17. The pooled estimate of mortality in mice after JEV challenge was 64.7% (95% confidence interval 60.9 to 68.3) with substantial heterogeneity between experimental groups (I^2 70.1%, df 486). Using meta-regression to identify key moderators, a refined dataset was used to model outcome dependent on five variables: mouse age, mouse strain, virus strain, virus dose (in log 10PFU) and route of inoculation. The final model reduced the heterogeneity substantially (I^2 38.9, df 265), explaining 54% of the variability.

          Conclusion/ Significance

          This is the first systematic review of mouse models of JEV infection. Better adherence to CAMARADES guidelines may reduce bias and variability of reporting. In particular, sample size calculations were notably absent. We report that mouse age, mouse strain, virus strain, virus dose and route of inoculation account for much, though not all, of the variation in mortality. This dataset is available for researchers to access and use as a guideline for JEV mouse experiments.

          Author summary

          Japanese encephalitis (JE) virus (JEV) remains a leading cause of brain infection across Asia, resulting in considerable death and disability. No effective treatment exists. Mouse models are fundamental to evaluate novel treatments. We aimed to perform the first systematic literature review and data synthesis of JEV infection in mouse models. We identified an abundance of experimental data in the field, with 127 studies meeting the inclusion criteria involving a total of 5026 individual mice. Overall, 64.7% of mice died after JEV infection. However, there was incomplete reporting in publications and considerable variability in the results. In summary, the findings support the ongoing use of mouse models of JEV infection and inform researchers in the field in refining their experiments. Key factors affecting variation in mortality across studies that need to be carefully considered in study design are mouse age, mouse strain, virus strain, virus dose and route of inoculation. We highlight the need for researchers to adhere to reporting guidelines in preparing manuscripts for publication.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Estimated global incidence of Japanese encephalitis: a systematic review

          OBJECTIVE: To update the estimated global incidence of Japanese encephalitis (JE) using recent data for the purpose of guiding prevention and control efforts. METHODS: Thirty-two areas endemic for JE in 24 Asian and Western Pacific countries were sorted into 10 incidence groups on the basis of published data and expert opinion. Population-based surveillance studies using laboratory-confirmed cases were sought for each incidence group by a computerized search of the scientific literature. When no eligible studies existed for a particular incidence group, incidence data were extrapolated from related groups. FINDINGS: A total of 12 eligible studies representing 7 of 10 incidence groups in 24 JE-endemic countries were identified.Approximately 67 900 JE cases typically occur annually (overall incidence: 1.8 per 100 000), of which only about 10% are reported to the World Health Organization. Approximately 33 900 (50%) of these cases occur in China (excluding Taiwan) and approximately 51 000 (75%) occur in children aged 0-14 years (incidence: 5.4 per 100 000). Approximately 55 000 (81%) cases occur in areas with well established or developing JE vaccination programmes, while approximately 12 900 (19%) occur in areas with minimal or no JE vaccination programmes. CONCLUSION: Recent data allowed us to refine the estimate of the global incidence of JE, which remains substantial despite improvements in vaccination coverage. More and better incidence studies in selected countries, particularly China and India, are needed to further refine these estimates.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Japanese encephalitis — the prospects for new treatments

            Japanese encephalitis is a mosquito-borne disease that occurs in Asia and is caused by Japanese encephalitis virus (JEV), a member of the genus Flavivirus. Although many flaviviruses can cause encephalitis, JEV causes particularly severe neurological manifestations. The virus causes loss of more disability-adjusted life years than any other arthropod-borne virus owing to the frequent neurological sequelae of the condition. Despite substantial advances in our understanding of Japanese encephalitis from in vitro studies and animal models, studies of pathogenesis and treatment in humans are lagging behind. Few mechanistic studies have been conducted in humans, and only four clinical trials of therapies for Japanese encephalitis have taken place in the past 10 years despite an estimated incidence of 69,000 cases per year. Previous trials for Japanese encephalitis might have been too small to detect important benefits of potential treatments. Many potential treatment targets exist for Japanese encephalitis, and pathogenesis and virological studies have uncovered mechanisms by which these drugs could work. In this Review, we summarize the epidemiology, clinical features, prevention and treatment of Japanese encephalitis and focus on potential new therapeutic strategies, based on repurposing existing compounds that are already suitable for human use and could be trialled without delay. We use our newly improved understanding of Japanese encephalitis pathogenesis to posit potential treatments and outline some of the many challenges that remain in tackling the disease in humans.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study

              Summary Background The past two decades have seen expansion of childhood vaccination programmes in low-income and middle-income countries (LMICs). We quantify the health impact of these programmes by estimating the deaths and disability-adjusted life-years (DALYs) averted by vaccination against ten pathogens in 98 LMICs between 2000 and 2030. Methods 16 independent research groups provided model-based disease burden estimates under a range of vaccination coverage scenarios for ten pathogens: hepatitis B virus, Haemophilus influenzae type B, human papillomavirus, Japanese encephalitis, measles, Neisseria meningitidis serogroup A, Streptococcus pneumoniae, rotavirus, rubella, and yellow fever. Using standardised demographic data and vaccine coverage, the impact of vaccination programmes was determined by comparing model estimates from a no-vaccination counterfactual scenario with those from a reported and projected vaccination scenario. We present deaths and DALYs averted between 2000 and 2030 by calendar year and by annual birth cohort. Findings We estimate that vaccination of the ten selected pathogens will have averted 69 million (95% credible interval 52–88) deaths between 2000 and 2030, of which 37 million (30–48) were averted between 2000 and 2019. From 2000 to 2019, this represents a 45% (36–58) reduction in deaths compared with the counterfactual scenario of no vaccination. Most of this impact is concentrated in a reduction in mortality among children younger than 5 years (57% reduction [52–66]), most notably from measles. Over the lifetime of birth cohorts born between 2000 and 2030, we predict that 120 million (93–150) deaths will be averted by vaccination, of which 58 million (39–76) are due to measles vaccination and 38 million (25–52) are due to hepatitis B vaccination. We estimate that increases in vaccine coverage and introductions of additional vaccines will result in a 72% (59–81) reduction in lifetime mortality in the 2019 birth cohort. Interpretation Increases in vaccine coverage and the introduction of new vaccines into LMICs have had a major impact in reducing mortality. These public health gains are predicted to increase in coming decades if progress in increasing coverage is sustained. Funding Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation.
                Bookmark

                Author and article information

                Contributors
                Role: Data curationRole: Formal analysisRole: InvestigationRole: MethodologyRole: Project administrationRole: SoftwareRole: VisualizationRole: Writing – original draft
                Role: Data curationRole: Formal analysisRole: InvestigationRole: MethodologyRole: Project administrationRole: VisualizationRole: Writing – original draft
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: Data curationRole: Writing – review & editing
                Role: MethodologyRole: Writing – review & editing
                Role: Formal analysisRole: MethodologyRole: Writing – review & editing
                Role: Formal analysisRole: Writing – review & editing
                Role: Formal analysisRole: MethodologyRole: SupervisionRole: VisualizationRole: Writing – review & editing
                Role: ConceptualizationRole: Data curationRole: Formal analysisRole: Funding acquisitionRole: InvestigationRole: MethodologyRole: Project administrationRole: ResourcesRole: SoftwareRole: SupervisionRole: VisualizationRole: Writing – original draftRole: Writing – review & editing
                Role: Editor
                Journal
                PLoS Negl Trop Dis
                PLoS Negl Trop Dis
                plos
                PLoS Neglected Tropical Diseases
                Public Library of Science (San Francisco, CA USA )
                1935-2727
                1935-2735
                10 February 2022
                February 2022
                : 16
                : 2
                : e0010116
                Affiliations
                [1 ] Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, United Kingdom
                [2 ] Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao PDR
                [3 ] Institute of Infection, Veterinary and Ecological Sciences, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom
                [4 ] Department of Neurology, Faculty of Medicine, Gadjah Mada University, Dr Sardjito Hospital, Yogyakarta, Indonesia
                [5 ] Department of Primary Care and Mental Health, University of Liverpool, Liverpool, United Kingdom
                [6 ] Tropical and Infectious Disease Unit, Liverpool University Hospitals NHS Foundation Trust (member of Liverpool Health Partners), Liverpool, United Kingdom
                Australian Red Cross Lifelood, AUSTRALIA
                Author notes

                The authors have declared that no competing interests exist.

                ‡ These authors share first authorship on this work.

                Author information
                https://orcid.org/0000-0002-6772-2855
                https://orcid.org/0000-0001-6989-3255
                https://orcid.org/0000-0002-6979-4369
                https://orcid.org/0000-0001-8028-7694
                https://orcid.org/0000-0002-2733-8410
                https://orcid.org/0000-0001-5809-8627
                https://orcid.org/0000-0003-0059-9247
                https://orcid.org/0000-0002-1734-9351
                https://orcid.org/0000-0002-3819-490X
                Article
                PNTD-D-21-01120
                10.1371/journal.pntd.0010116
                8865681
                35143497
                e0ec2c90-e931-4cc4-a021-b01e36d271bf
                © 2022 Bharucha et al

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 28 July 2021
                : 19 December 2021
                Page count
                Figures: 9, Tables: 2, Pages: 18
                Funding
                Funded by: University of Oxford and the Medical Research Council
                Award ID: MR/N013468/1
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/100004440, wellcome trust;
                Award ID: 205228/Z/16/Z
                Award Recipient :
                Funded by: NIHR Health Protection Research Unit in emerging and zoonotic infections
                Award ID: NIHR200907
                Award Recipient :
                Funded by: Oxford Glycobiology endowment
                Award Recipient :
                TB is supported by the University of Oxford and the Medical Research Council [grant number MR/N013468/1]. LT is a Wellcome clinical career development fellow, supported by grant number 205228/Z/16/Z, and the NIHR Health Protection Research Unit in emerging and zoonotic infections (NIHR200907) at University of Liverpool in partnership with Public Health England (PHE), in collaboration with Liverpool School of Tropical Medicine and the University of Oxford. LT is based at University of Liverpool. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England. NZ is supported by the Oxford Glycobiology endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article
                Research and Analysis Methods
                Animal Studies
                Experimental Organism Systems
                Model Organisms
                Mouse Models
                Research and Analysis Methods
                Model Organisms
                Mouse Models
                Research and Analysis Methods
                Animal Studies
                Experimental Organism Systems
                Animal Models
                Mouse Models
                Research and Analysis Methods
                Animal Studies
                Animal Models of Disease
                Animal Models of Infection
                Biology and Life Sciences
                Microbiology
                Animal Models of Infection
                Research and Analysis Methods
                Mathematical and Statistical Techniques
                Statistical Methods
                Metaanalysis
                Physical Sciences
                Mathematics
                Statistics
                Statistical Methods
                Metaanalysis
                Research and Analysis Methods
                Research Assessment
                Systematic Reviews
                Medicine and Health Sciences
                Pharmacology
                Routes of Administration
                Research and Analysis Methods
                Animal Studies
                Animal Models of Disease
                Medicine and Health Sciences
                Medical Conditions
                Infectious Diseases
                Infectious Diseases of the Nervous System
                Encephalitis
                Japanese Encephalitis
                Medicine and Health Sciences
                Neurology
                Infectious Diseases of the Nervous System
                Encephalitis
                Japanese Encephalitis
                Medicine and Health Sciences
                Medical Conditions
                Tropical Diseases
                Neglected Tropical Diseases
                Japanese Encephalitis
                Medicine and Health Sciences
                Medical Conditions
                Infectious Diseases
                Viral Diseases
                Japanese Encephalitis
                Research and Analysis Methods
                Research Assessment
                Research Reporting Guidelines
                Custom metadata
                vor-update-to-uncorrected-proof
                2022-02-23
                Data are available as supplemental information.

                Infectious disease & Microbiology
                Infectious disease & Microbiology

                Comments

                Comment on this article